SinoMab BioScience Ltd. held its annual general meeting on June 30, 2025. During the meeting, all proposed resolutions were approved, except for one which was withdrawn. The proposals included the appointment of independent non-executive directors and changes in the composition of board committees. The company also re-complied with Rule 3.27A of the Listing Rules.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.